SELLAS Life Sciences Group has signed a definitive agreement to merge with Galena Biopharma.
SELLAS will become a wholly owned subsidiary of Galena, following the completion of the merger.
Go deeper with GlobalData
SELLAS is a clinical-stage biopharmaceutical company based in Bermuda, while Galena Biopharma is a late-stage biopharmaceutical company based in the US.
Clinical-stage pharmaceutical company Cempra plans to merge with commercial-stage biopharmaceutical company, Melinta Therapeutics.
The merged entity will be known as Melinta Therapeutics.
Both companies involved in the merger are based in the US.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData
